BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
South Korea · Delayed Price · Currency is KRW 5,270.00
+10.00 (0.19%)
At close: Feb 5, 2026
BCWORLD PHARM. Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -3,765 | -4,433 | 2,634 | 281.3 | -1,843 | -1,580 |
Depreciation & Amortization | 7,848 | 7,694 | 7,470 | 7,208 | 5,174 | 4,569 |
Loss (Gain) From Sale of Assets | 135.1 | -20.77 | -48.91 | 0.32 | 0 | -197.09 |
Asset Writedown & Restructuring Costs | - | - | - | 64.29 | - | - |
Loss (Gain) From Sale of Investments | 85.69 | 28.94 | -13.42 | 535.17 | 229.14 | - |
Provision & Write-off of Bad Debts | 443.98 | 55.52 | 223.05 | 34.91 | 49.77 | 67.29 |
Other Operating Activities | 3,723 | 2,068 | 642.45 | -1,251 | -2,522 | -3,361 |
Change in Accounts Receivable | -2,272 | -2,619 | -1,652 | -1,520 | -1,236 | 1,477 |
Change in Inventory | -4,446 | 2,000 | -299.31 | -618.65 | -813.45 | -1,166 |
Change in Accounts Payable | 2,418 | 172.23 | -97.11 | 1,381 | -1,420 | -2,002 |
Change in Other Net Operating Assets | -116.18 | -903.84 | 2,080 | 767.78 | 1,762 | -3,310 |
Operating Cash Flow | 4,118 | 4,042 | 10,938 | 6,883 | -619.83 | -5,502 |
Operating Cash Flow Growth | -42.69% | -63.04% | 58.91% | - | - | - |
Capital Expenditures | -3,491 | -2,398 | -2,577 | -6,217 | -17,444 | -7,785 |
Sale of Property, Plant & Equipment | - | 41.93 | 64.27 | 192.36 | 106.58 | 157.03 |
Sale (Purchase) of Intangibles | -18.24 | -9.95 | -132.03 | -47.31 | -1,201 | 188.81 |
Sale (Purchase) of Real Estate | - | - | - | -174.45 | -165 | -112.48 |
Investment in Securities | -1,448 | 1,266 | -553.23 | -862.35 | -5.74 | -665.37 |
Other Investing Activities | 2.75 | -38.65 | 81.06 | 431 | 1,020 | 105.05 |
Investing Cash Flow | -4,955 | -1,139 | -3,764 | -6,678 | -17,690 | -8,112 |
Long-Term Debt Issued | - | 30,693 | 35,830 | 35,680 | 30,700 | 53,687 |
Long-Term Debt Repaid | - | -34,674 | -39,535 | -32,951 | -19,509 | -35,970 |
Net Debt Issued (Repaid) | 206.28 | -3,980 | -3,705 | 2,729 | 11,191 | 17,717 |
Repurchase of Common Stock | -10.88 | - | - | -806.57 | - | -24.32 |
Dividends Paid | -542.73 | -542.73 | -542.73 | -853.86 | -853.86 | -771.83 |
Other Financing Activities | 50 | - | -0 | 3.7 | -0 | 6,000 |
Financing Cash Flow | -297.33 | -4,523 | -4,248 | 1,073 | 10,337 | 22,921 |
Foreign Exchange Rate Adjustments | 53.67 | 68.01 | 38.01 | -1.7 | 48.29 | -311.28 |
Net Cash Flow | -1,081 | -1,551 | 2,963 | 1,276 | -7,925 | 8,995 |
Free Cash Flow | 626.48 | 1,644 | 8,361 | 666.21 | -18,064 | -13,288 |
Free Cash Flow Growth | -86.47% | -80.33% | 1154.97% | - | - | - |
Free Cash Flow Margin | 0.81% | 2.20% | 11.13% | 0.92% | -29.10% | -23.30% |
Free Cash Flow Per Share | 61.27 | 161.05 | 818.82 | 64.61 | -1748.42 | -1290.57 |
Cash Interest Paid | 3,659 | 4,102 | 4,474 | 2,811 | 1,851 | 1,925 |
Cash Income Tax Paid | 57.43 | 117.07 | -1,291 | -85.77 | 1,100 | 231.5 |
Levered Free Cash Flow | 1,691 | 2,470 | 5,224 | -2,496 | -63,484 | 31,885 |
Unlevered Free Cash Flow | 4,368 | 5,445 | 8,495 | -125.88 | -62,129 | 33,397 |
Change in Working Capital | -4,417 | -1,350 | 31.16 | 9.65 | -1,708 | -5,001 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.